Biotech Values

[masterlongevity]

what parts? all they have is the cash and the tysabri royalty. There is nothing else except inept mgmt that is ridiculously paid and bloated SG and A spending. they have started 3 ph 2 trials for ELND005 in indications of which therir is no clear rationale for the MOA. those are just throwing away money.

ELND005 was heavily heavily shopped for 2 yrs with no takers.

Bapi is dead and ACC has a very very low chance of success.

I think this is a good offer.